Skip to main content
OpenTrials

Clinical trial condition

Urogenital Abnormalities

Explore clinical trials studying Urogenital Abnormalities. Study availability and eligibility vary by location and protocol.

436 public trials 100 recruiting studies
Refine in advanced search Browse all conditions

Urogenital Abnormalities trial results

Completed

An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG

NCT00250250

Conditions
Cardiovascular Abnormalities, Cardiovascular Diseases, Chromosome Disorders, +18 more
Locations
  • Faculty Hospital Olomouc, Children's Clinic, Endocrinology Outpatient Department, I.P.Pavlova str. 6, Olomouc, Czechia
  • Faculty Hospital Kralovske Vinohrady, Children's Clinic, Vinohradska str. 159 Prague, Czechia
  • Masaryk Hospital Usti nad Labem, Children's Clinic, Building D2, Endocrinology Outpatient Department, Socialni pece 12a Ústí nad Labem, Czechia
  • Centre d'Endocrinologie Pediatrique, 25 rue Boudet Bordeaux, France
View Trial Details
Completed

Somatropin Treatment to Final Height in Turner Syndrome

NCT00191113

Conditions
Bone Diseases, Bone Diseases, Developmental, Cardiovascular Abnormalities, +25 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Calgary, Alberta, Canada
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Edmonton, Alberta, Canada
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vancouver, British Columbia, Canada
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Winnipeg, Manitoba, Canada
View all 14 locations
View Trial Details
Completed

Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker

NCT00770458

Conditions
Abnormalities, Multiple, Cardiovascular Abnormalities, Cardiovascular Diseases, +28 more
Locations
  • UCSD Fetal Care & Genetics Center La Jolla, California, United States
  • San Diego Perinatal Center San Diego, California, United States
  • Obstetrix Medical Group of San Jose San Jose, California, United States
  • Obstetrix Medical Group of Colorado Denver, Colorado, United States
View Trial Details

Related conditions